<DOC>
	<DOCNO>NCT00004347</DOCNO>
	<brief_summary>OBJECTIVES : I . Examine intestinal absorption dietary cholesterol patient Smith-Lemli-Opitz syndrome . II . Measure effect dietary cholesterol plasma sterol composition . III . Quantify basal cholesterol synthesis , turnover cholesterol 7-dehydrocholesterol , effect dietary cholesterol parameter . IV . Identify fecal bile acid excretion quantitatively qualitatively patient . V. Compare incorporation deuterated water plasma cholesterol , 7-dehydrocholesterol , intermediate , assess effect dietary cholesterol incorporation .</brief_summary>
	<brief_title>Phase II Study Dietary Cholesterol Smith-Lemli-Opitz Syndrome</brief_title>
	<detailed_description>PROTOCOL OUTLINE : Patients treat 2 dietary regimen 1 3 week : high cholesterol cholesterol-free . Cholesterol provide form egg yolk . The absorption metabolism cholesterol evaluate plasma fecal study . Deuterated water give patient follow analysis deuterium plasma cholesterol intermediate , include 7-dehydrocholesterol .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Cleft Palate</mesh_term>
	<mesh_term>Hypertelorism</mesh_term>
	<mesh_term>Hypospadias</mesh_term>
	<mesh_term>Genetic Diseases , X-Linked</mesh_term>
	<mesh_term>Smith-Lemli-Opitz Syndrome</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : SmithLemliOpitz syndrome</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2003</verification_date>
	<keyword>Smith-Lemli-Opitz syndrome</keyword>
	<keyword>genetic disease dysmorphic syndrome</keyword>
	<keyword>rare disease</keyword>
</DOC>